🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to Dr. Dan Barouch, Chief of the Division of Virology & Vaccine Research and Director of Barouch Lab, on receiving the 2023 Paragon Award for Research Excellence from the Doris Duke Foundation! He was presented with the award last week in New York City 🌟🔬🎉

Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques Barouch Lab nature nature.com/articles/s4158…

Robust mucosal immunity vs Covid, which can achieved by an inhalation vaccine (IT below), in non-human primates, provided near complete protection for blocking infections, greatly exceeding that of shots. nature.com/articles/s4158… Barouch Lab

mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer jitc.bmj.com/content/12/1/e…

“We are not going to be able to completely stop transmission, and we’re not going to be able to get rid of this virus in the human population,” said Dr. Dan Barouch. Click the link to read the full article: amp.cnn.com/cnn/2024/01/23…

Our new paper on immunity of bivalent mRNA boosters and IgG profiling, especially IgG4 responses after 3rd and 4th mRNA vaccination is out on Science Advances today! Barouch Lab Ai-ris Yonekura Collier, MD Ryan McNamara 🧬 science.org/doi/10.1126/sc…

Our new brief report on the neutralization of Omicron subvariant BA.2.87.1 is now out on Elsevier Vaccine! A great and rapid team effort from Annika Rössler, PhD Marjorie Rowe Ai-ris Yonekura Collier, MD Barouch Lab sciencedirect.com/science/articl…

MVA and multivalent Ad35-based vaccines induced robust protection against Mpox challenge in nonhuman primates, whereas ACAM200 induced near complete protection Science Translational Medicine Barouch Lab science.org/doi/10.1126/sc…

A new head-to-head comparison of approved #mpox vaccines and vaccine candidates sheds light on their protective efficacy, and reveals promising immune correlates of protection that could inform future vaccine research. Barouch Lab BIDMC_CVVRtrial scim.ag/6oH

Join us on April 25 for the #HIRM 10 Year Anniversary #RNA Medicine Symposium feat. Dr. Dan Barouch, MD, PhD Director of the Barouch Lab BIDMC + Harvard Medical School. His lab specializes in #immunology and pathogenesis of viral infections. Register now: bit.ly/48CFa0F

jobs.bilh.org/job/boston/adm…

A new Covid variant has taken over, and experts predict a small summer wave cvvr.hms.harvard.edu/?p=10310

Ahead of #HIVVaccineAwarenessDay JIAS has published a new viewpoint, “The potential of broadly neutralizing antibodies for HIV prevention”. Read it here: bit.ly/4bHHTHj #HVAD Huub Gelderblom, MD, PhD, MPH Barouch Lab

This study shows that mpox antibody responses generated by the MVA-BN vaccine wane significantly within 6 to 12 months, potentially leaving individuals vulnerable to reinfection. ja.ma/47UtpTG

New data from BIDMC Barouch Lab suggests that protective immunity against #Mpox may have waned in previously vaccinated individuals and that boosting may be required to maintain robust protection

It took some time for this to come out, but I am glad it's out now Science Translational Medicine!!! It was a huge effort by our team Barouch Lab Ai-ris Yonekura Collier, MD Camille Mazurek and many more to evaluate mucosal immune responses, 4 years into the COVID-19 pandemic. science.org/doi/10.1126/sc…

I'm very excited to share our recent paper describing the antigenic relationship of SARS-CoV-2 variants in Nonhuman primates for the first time. Barouch Lab anetzl Ninaad Lasrado, PhD Janine Kimpel Cambridge University Medizinische Uni cell.com/cell-reports/f…

#LongCovid has impaired millions of people, with no cure on the horizon. BIDMC_CVVRtrial has launched a trial to test Abrocitinib to alleviate LC symptoms. If you’re around Boston, see if you qualify! 👇Dianna Cowern Michal Tal, PhD Eric Topol Prof. Akiko Iwasaki LongCOVIDCampaign